C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/4439 (2006.01) A61P 1/16 (2006.01) A61P 1/18 (2006.01) A61P 9/10 (2006.01) A61P 11/00 (2006.01) A61P 13/12 (2006.01) A61P 17/06 (2006.01) A61P 19/02 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01) A61P 31/04 (2006.01) A61P 37/06 (2006.01) A61P 37/08 (2006.01) C07D 231/12 (2006.01) C07D 401/14 (2006.01)
Patent
CA 2596993
Compound that as compared with the racemate thereof, is highly enhanced in not only C5a receptor antagonistic activity but also extent of bioavailability, represented by the formula (I). Further, there are provided its pharmacologically acceptable salts, or hydrates or solvates thereof.
La présente invention concerne un composé qui, par comparaison avec son racémate, présente non seulement une activité antagoniste du récepteur du C5a fortement amplifiée mais également un degré de biodisponibilité fortement accru. Ce composé est représenté par la formule: [Formule Chimique 1] (I). L'invention concerne en outre les sels, les hydrates ou les solvates pharmacologiquement acceptables de ce composé.
Ishibuchi Seigo
Ishige Takayuki
Nakamura Mitsuharu
Ohtsuka Tatsuyuki
Sekiguchi Sumie
Fetherstonhaugh & Co.
Mitsubishi Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Optically active tetrahydronaphthalene derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optically active tetrahydronaphthalene derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically active tetrahydronaphthalene derivative will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1363773